Clinical OMICS

MAY-JUN 2018

Healthcare magazine for research scientists, labs, pathologists, hospitals, cancer centers, physicians and biopharma companies providing news articles, expert interviews and videos about molecular diagnostics in precision medicine

Issue link:

Contents of this Issue


Page 2 of 51

VOL. 5, Issue No. 3 May/June 2018 May/June 2018 Clinical OMICs 1 @ClinicalOMICs 30| DATA & INFORMATICS Learning the Literature: Genomenon, Veritas Collaborate on Next-Gen Publication Prioritization Engine 34 | IN THE LAB Dark Side of the Genome: Study Links Noncoding Mutations in Regulatory Regions of the Cancer Genome to Altered Gene Expression 39 | NEW PRODUCTS 40 | FEATURE 10 U.S.Startups to Watch 44 | PRECISION MEDICINE Ready for Prime Time?: AI Influencing Precision Medicine but May Not Match the Hype 48 | INDUSTRY EVENTS Breaking NGS Ground CMS Final Coverage Determination Promotes Sequencing-Based Testing for Advanced Cancer 20 A Resolution Revolution Single-cell Sequencing Techniques are Providing Significant Advances Across a Broad Swath of Fields 26 3 | NEWS Pollution and Genes Work Together to Increase Severity of Rheumatoid Arthritis 10 | FROM THE EDITOR Is it Time to Sequence Everyone's Genome? Not Yet. 11 | OP-ED Why Amazon, JPM, and Berkshire Hathaway Can Succeed with Healthcare 12 | FEATURE Cost Conscious: MedSeq Project Provides Snapshot to Suggest Genomic Sequencing Does Not Increase Downstream Healthcare Costs 16 | DIAGNOSTICS Wrangle Over DTC Results: Ambry Study Highlights 40% False Positives Cover: Mon Oo Yee; Above (top right): Caris Life Science; (top left) ALFRED PASIEKA/SCIENCE PHOTO LIBRARY /Getty Images; (middle left) JodiJacobson / Getty Images; (middle right) wildpixel / Getty Images.

Articles in this issue

Links on this page

Archives of this issue

view archives of Clinical OMICS - MAY-JUN 2018